Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?

Wendy O. Henderson, MD, Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP and Bryan C. Batch, MD, MHS
Cleveland Clinic Journal of Medicine February 2021, 88 (2) 81-85; DOI: https://doi.org/10.3949/ccjm.88a.19135
Wendy O. Henderson
Associate Chief of Staff, Ambulatory Care Service, Durham VA Health Care System; Assistant Professor, Department of Medicine, Duke University, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary H. Parker
Acting Chief Medical Officer, VA Mid-Atlantic Health Care Network (VISN6); Clinical Coordinator/Clinical Pharmacy Specialist, Pharmacy and Ambulatory Care, Durham VA Health Care System, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Bryan C. Batch
Endocrine Section Chief, Durham VA Health Care System; Associate Professor of Medicine, Duke University Division of Endocrinology, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 88 no. 2 81-85
DOI 
https://doi.org/10.3949/ccjm.88a.19135
PubMed 
33526460

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online February 1, 2021.

Copyright & Usage 
Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Wendy O. Henderson, MD
  1. Associate Chief of Staff, Ambulatory Care Service, Durham VA Health Care System; Assistant Professor, Department of Medicine, Duke University, Durham, NC
  1. Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP⇑
  1. Acting Chief Medical Officer, VA Mid-Atlantic Health Care Network (VISN6); Clinical Coordinator/Clinical Pharmacy Specialist, Pharmacy and Ambulatory Care, Durham VA Health Care System, Durham, NC
  1. Address:
    Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP, Pharmacy and Ambulatory Care, Durham VA Health Care System, 508 Fulton Street (11-C), Durham, NC 27705; mary.h.parker{at}gmail.com
  1. Bryan C. Batch, MD, MHS
  1. Endocrine Section Chief, Durham VA Health Care System; Associate Professor of Medicine, Duke University Division of Endocrinology, Durham, NC
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 88 (2)
Cleveland Clinic Journal of Medicine
Vol. 88, Issue 2
1 Feb 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
Wendy O. Henderson, Mary H. Parker, Bryan C. Batch
Cleveland Clinic Journal of Medicine Feb 2021, 88 (2) 81-85; DOI: 10.3949/ccjm.88a.19135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
Wendy O. Henderson, Mary H. Parker, Bryan C. Batch
Cleveland Clinic Journal of Medicine Feb 2021, 88 (2) 81-85; DOI: 10.3949/ccjm.88a.19135
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • HEMOGLOBINOPATHIES CAN INTERFERE WITH HEMOGLOBIN A1c
    • ALTERNATIVE METHODS TO ASSESS LONG-TERM GLYCEMIC CONTROL
    • EDUCATING PATIENTS AND PROVIDERS ON ALTERNATIVE TESTS
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Low circulating adropin levels in late-middle aged African Americans with poor cognitive performance
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Diabetes
  • Drug Therapy
  • Endocrinology
  • Geriatrics
  • Hematology
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire